Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gedda

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 28, 2026
Revealing the Morphology of Small Multilamellar Lipid Nanoparticles (SMLPs) made by In-Vial HomogenizationSevda Akcesme, Stefanie Schmager, Yassir Al-Tikriti, et al.
Bioconjugate Chemistry|August 14, 2012
Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2Lina Ekerljung, Helena Wållberg, Azita Sohrabian, et al.
Molecular Pharmaceutics|February 28, 2022
Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering TechniquesDileep Urimi, Maja Hellsing, Najet Mahmoudi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2003
Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGFAsa Liljegren Sundberg, Ylva Almqvist, Anna Orlova, et al.
Soft Matter|August 5, 2021
Investigation of the enhanced ability of bile salt surfactants to solubilize phospholipid bilayers and form mixed micellesVahid Forooqi Motlaq, Mattias Ortega-Holmberg, Katarina Edwards, et al.
International Journal of Oncology|October 8, 2005
An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assayErika Bohl Kullberg, Bo Stenerlöw, Senait Ghirmai, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 5, 2013
Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissueLars Gedda, Hanna Björkelund, Lena Lebel, et al.
Journal of Materials Science. Materials in Medicine|February 9, 2013
Morphological differences in BMP-2-induced ectopic bone between solid and crushed hyaluronan hydrogel templatesGry Hulsart-Billström, Sonya Piskounova, Lars Gedda, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Biotechnology and Applied Biochemistry|June 5, 2009
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody moleculeMikaela Friedman, Sara Lindström, Lina Ekerljung, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 28, 2026
Revealing the Morphology of Small Multilamellar Lipid Nanoparticles (SMLPs) made by In-Vial HomogenizationSevda Akcesme, Stefanie Schmager, Yassir Al-Tikriti, et al.
Bioconjugate Chemistry|August 14, 2012
Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2Lina Ekerljung, Helena Wållberg, Azita Sohrabian, et al.
Molecular Pharmaceutics|February 28, 2022
Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering TechniquesDileep Urimi, Maja Hellsing, Najet Mahmoudi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2003
Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGFAsa Liljegren Sundberg, Ylva Almqvist, Anna Orlova, et al.
Soft Matter|August 5, 2021
Investigation of the enhanced ability of bile salt surfactants to solubilize phospholipid bilayers and form mixed micellesVahid Forooqi Motlaq, Mattias Ortega-Holmberg, Katarina Edwards, et al.
International Journal of Oncology|October 8, 2005
An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assayErika Bohl Kullberg, Bo Stenerlöw, Senait Ghirmai, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 5, 2013
Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissueLars Gedda, Hanna Björkelund, Lena Lebel, et al.
Journal of Materials Science. Materials in Medicine|February 9, 2013
Morphological differences in BMP-2-induced ectopic bone between solid and crushed hyaluronan hydrogel templatesGry Hulsart-Billström, Sonya Piskounova, Lars Gedda, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Biotechnology and Applied Biochemistry|June 5, 2009
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody moleculeMikaela Friedman, Sara Lindström, Lina Ekerljung, et al.
Pageof 7